Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02290951
Brief Title: A Phase 1 Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies

First Submitted : November 7, 2014
First Submitted that Met QC Criteria : November 11, 2014
First Posted : November 14, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 5, 2019
Last Update Posted : November 7, 2019